What is the relationship between perimenopause and celiac disease (CD) and bipolar disorder (BD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 11, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

There is no established direct connection between perimenopause, celiac disease, and bipolar disorder, though hormonal fluctuations during perimenopause may potentially influence symptoms of pre-existing conditions. Perimenopause involves significant hormonal changes, particularly decreasing estrogen, which can affect mood and may temporarily worsen symptoms in women who already have bipolar disorder, as suggested by a study on the risk of suicidal behavior in patients with major depression and bipolar disorder 1. These hormonal shifts don't cause celiac disease or bipolar disorder but might impact their management. For women with celiac disease, maintaining a strict gluten-free diet remains essential during perimenopause, as supported by guidelines on osteoporosis in gastrointestinal diseases 1. For those with bipolar disorder, medication adjustments may be necessary as hormonal changes can affect how medications are metabolized. Common bipolar medications include mood stabilizers (lithium, valproate), antipsychotics (quetiapine, olanzapine), and antidepressants (always used cautiously and typically with mood stabilizers). Women experiencing perimenopause who have either condition should work closely with their healthcare providers to monitor symptoms and adjust treatment as needed. The relationship between these conditions is complex and individualized, with hormonal fluctuations potentially serving as a common factor that can influence symptom expression rather than indicating a causal relationship.

Some key considerations for managing these conditions include:

  • Monitoring bone density in women with celiac disease, especially during perimenopause, as they are at increased risk for osteoporosis 1.
  • Adjusting medications for bipolar disorder during perimenopause to account for changes in hormone levels and their potential impact on medication metabolism.
  • Recognizing the potential for increased risk of suicidal behavior in patients with bipolar disorder, particularly during periods of significant hormonal change like perimenopause, and taking proactive measures to monitor and manage this risk 1.

Overall, while there is no direct connection between perimenopause, celiac disease, and bipolar disorder, understanding the potential interactions and impacts of hormonal changes on these conditions is crucial for providing comprehensive care.

From the Research

Connection between Perimenopause and Bipolar Disorder

  • The menopausal transition, or perimenopause, can represent a time of increased vulnerability to depression and a greater risk of recurrence or instability of bipolar disorder 2.
  • Treatments for the symptoms of menopause and for unipolar or bipolar disorder need to be chosen with careful consideration for the different stages of the menopausal transition, as well as safety, tolerability, and impact on quality of life 2.
  • Bipolar disorder presents differently in women than in men and may require different medication, such as lithium, valproate, or carbamazepine, which can affect bone mineral density and quality of life 2, 3.

Connection between Perimenopause and Celiac Disease

  • There is no direct evidence in the provided studies to suggest a connection between perimenopause and celiac disease.

Connection between Celiac Disease and Bipolar Disorder

  • There is no direct evidence in the provided studies to suggest a connection between celiac disease and bipolar disorder.

Management of Perimenopause and Bipolar Disorder

  • The appropriate evaluation and evidence-based management of women in the perimenopausal transition is crucial, and treatments such as hormonal therapies, antidepressants, and herbal supplements can be used to manage menopausal symptoms 4, 5.
  • Lithium and valproate are commonly used to treat bipolar disorder, but their effectiveness can vary depending on individual factors, such as family history, previous affective episodes, and comorbidities 6, 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Lithium and Valproate in Bipolar Disorder: From International Evidence-based Guidelines to Clinical Predictors.

Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology, 2022

Research

Management of the Perimenopause.

Clinical obstetrics and gynecology, 2018

Research

Perimenopause: From Research to Practice.

Journal of women's health (2002), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.